Clovis Oncology

Clovis Oncology

Clovis Oncology

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
Founded
2009
Raised
$145M
Follow us
Alexa global traffic share
Twitter followers
Team Size
1–10
Employees
The Motley Fool

Why Clovis Oncology, Inc. Sank 28.2% in April

The Motley Fool

Clovis Oncology's Failure Is a Big Win for AstraZeneca

The Motley Fool

Why Horizon Pharma, Och-Ziff Capital Management, and Clovis Oncology Slumped Today

Stock markets
The Motley Fool

Why Ruby Tuesday, Clovis Oncology, and G-III Apparel Group Slumped Today

Earnings Stock markets
The Motley Fool

Why Shaken Confidence Caused Clovis Oncology, Inc. to Crash in November --

The Motley Fool

Clovis Oncology's Loss Could Be a Win for AstraZeneca --

The Motley Fool

Why Clovis Oncology Inc Is Falling Again --

Stock markets Health
The Motley Fool

Why Clovis Oncology, Dillard's, and Urban Outfitters Slumped Today --

Stock markets Earnings